March 15, 2022

Acta affiliate B&C Quoted in Chemical Watch Article “Plan to exclude PPE from TSCA risk evaluations sparks industry outcry”

On March 14, 2022, The Acta Group (Acta®) affiliate Bergeson & Campbell, P.C. (B&C®) was quoted by Chemical Watch on the U.S. Environmental Protection Agency’s (EPA) decision to no longer consider personal protective equipment (PPE) use in Toxic Substances Control Act (TSCA) risk evaluations.  Law firm Bergeson & Campbell said assuming PPE will not be used, including in cases where required by the Occupational Safety and Health...
March 2, 2022

Lynn L. Bergeson Quoted in Chemical Watch Article “EPA to scrap TSCA inventory corrections process”

On March 1, 2022, Lynn L. Bergeson, President, The Acta Group (Acta®), was quoted by Chemical Watch responding to the U.S. Environmental Protection Agency’s (EPA) announcement that it will no longer allow companies to request corrections to the Toxic Substances Control Act (TSCA) inventory and instead require them to submit a pre-manufacture notice (PMN) for improperly identified substances.   The decision “is entirely unprincipled and based on a...
March 1, 2022

Richard E. Engler, Ph.D., Quoted in Bloomberg Law Article “EPA Drops Policy Chemical Makers Use to Correct Critical List”

On Feburary 28, 2022, Richard E. Engler, Ph.D., Director of Chemistry with The Acta Group (Acta®), was quoted by Bloomberg Law regarding the U.S. Environmental Protection Agency’s (EPA) announcement that, as of April 26, it will no longer process chemical manufacturers’ requests to correct the specific ways chemicals on the Toxic Substances Control Act (TSCA) inventory are identified. If the EPA is concerned that companies are using correction requests to add new...
February 16, 2022

Lynn L. Bergeson and Richard E. Engler, Ph.D., Quoted by Inside TSCA in “Industry Sees NAMs Aiding New Chemical Reviews, But Laments PPE Delays”

On February 15, 2022, Lynn L. Bergeson, President, The Acta Group (Acta®), and Richard E. Engler, Ph.D., Director of Chemistry, Acta, were quoted by Inside TSCA regarding the U.S. Environmental Protection Agency’s (EPA) application of new approach methods (NAMs) and category-based analyses for new-chemical reviews.  An industry attorney says EPA’s application of new approach methods (NAMs) and category-based analyses for new-chemical reviews is helping...
January 24, 2022

Chemical Watch Quotes Richard E. Engler, Ph.D., Regarding CBI Claim Issues

On January 24, 2022, Chemical Watch quoted Richard E. Engler, Ph.D., Director of Chemistry with The Acta Group (Acta®), in the article “Proposal on the horizon to update TSCA confidentiality procedures.” According to Richard Engler, director of chemistry at industry law firm Bergeson & Campbell and a 17-year veteran of the EPA, this could be aimed at ensuring the agency can get in touch with CBI claim holders.   “One of the challenges EPA...
January 5, 2022

Register Now for “What to Expect in Chemicals in 2022”

2022 will bring competing priorities for the U.S. Environmental Protection Agency (EPA) for which companies should now prepare. The Acta Group (Acta®) affiliate Bergeson & Campbell, P.C. (B&C®) is pleased to present “What to Expect in Chemicals in 2022,” a webinar offering our best informed judgment as to the trends and key developments B&C’s legal, scientific, and regulatory professionals expect to see in 2022. These include consequential policy shifts reflecting the...
January 3, 2022

The Acta Group Releases 2022 Forecast for U.S. Federal and International Chemical Regulatory Policy

Bergeson & Campbell, P.C. (B&C®) and its consulting affiliate The Acta Group (Acta®) and consortia management affiliate B&C® Consortia Management, L.L.C. (BCCM) are pleased to offer you our Forecast 2022. The extraordinary diversity and complexity of global industrial, agricultural, and biocidal chemical initiatives in which our clients engage are reflected in the detailed summary that follows, prepared by the legal, scientific, and regulatory professionals of B&C,...
December 15, 2021

Lynn L. Bergeson and Christopher R. Blunck Quoted by Bloomberg Law in “EPA to Miss Chemical Deadlines, Exposing Public to Risks”

On December 14, 2021, Lynn L. Bergeson, President, The Acta Group (Acta®), and Christopher R. Blunck, Senior Regulatory Specialist, Acta, were quoted by Bloomberg Law regarding the U.S. Environmental Protection Agency’s (EPA) recently released regulatory agenda that “anticipates the agency missing at least five of 10 deadlines the 2016 Toxic Substances Control Act (TSCA) amendments set to restrict too-risky chemicals already on the U.S. market” and...
December 13, 2021

Richard E. Engler, Ph.D., Quoted by Bloomberg Law in “EPA Stops Posting ‘Critically Important’ Chemical Risk Data”

On December 13, 2021, Richard E. Engler, Ph.D., Director of Chemistry, The Acta Group (Acta®) was quoted by Bloomberg Law regarding a substantial decrease in chemical data being posted to the ChemView database by the U.S. Environmental Protection Agency (EPA) due to resource constraints. This information is used by the public, industry, and environmental groups to easily access health and safety information for hundreds of chemicals. Businesses might need the information to...
November 29, 2021

Lynn L. Bergeson and Richard E. Engler, Ph.D., Quoted by Bloomberg Law in “Chemical Makers Face First of Two EPA Fee Hikes”

On November 24, 2021, Lynn L. Bergeson, President, The Acta Group (Acta®), and Richard E. Engler, Ph.D., Director of Chemistry, Acta, were quoted by Bloomberg Law regarding planned increases for Toxic Substances Control Act (TSCA) fees.  Lynn L. Bergeson, managing partner, with Bergeson and Campbell PC, said EPA’s fee revisions will be the “main event” for companies to watch. Tuesday’s announcement appears to be the statute’s routine adjustment to fees...